The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of KN035, the first subcutaneously administered, novel fusion anti-PD-L1 antibody in patients with advanced solid tumors in China.
 
Jian-Ming Xu
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Yun Zhang
No Relationships to Disclose
 
Yaoyue Zhang
No Relationships to Disclose
 
Ru Jia
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Gairong Zhang
No Relationships to Disclose
 
Chuanhua Zhao
No Relationships to Disclose
 
Ni Lu
Employment - 3D Medicines
 
Huilong Liu
Employment - 3D Medicines; Hengrui Pharmaceutical
Leadership - Hengrui Pharmaceutical
Stock and Other Ownership Interests - Hengrui Pharmaceutical
 
Wenlian Xu
Employment - 3D Medicines
Leadership - 3D Medicines
 
Meng Fu
Employment - 3D Medicines; MedImmune
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca
 
Walt Cao
Employment - 3D Medicines
Other Relationship - FDA
 
Haolan Lu
Employment - 3D Medicines; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Liu
Employment - 3D Medicines
Stock and Other Ownership Interests - 3D Medicines; Celgene
Other Relationship - 3D Medicines; Celgene
 
Ruiping Dong
No Relationships to Disclose
 
Xiaoxiao Wang
No Relationships to Disclose
 
Pilin Wang
No Relationships to Disclose
 
Ting Xu
No Relationships to Disclose
 
John Gong
Employment - 3D Medicines
Leadership - 3D Medicines
Stock and Other Ownership Interests - 3D Medicines